GAROFALO ELIZABETH A.

ACAD

GAROFALO ELIZABETH A. serves as Director at ACADIA Pharmaceuticals Inc. (ACAD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$131.2K

Net Position

Net Seller

$131.2K

Companies Traded

ACAD

Active Period

Mar 2025 – Sep 2025

2 total trades

Most Recent

Sell ACAD

Sep 2, 2025 · $41.6K

GAROFALO ELIZABETH A.'s Insider Trading at ACADIA Pharmaceuticals Inc. (ACAD)

Buys

0 · $0.00

Sells

2 · $131.2K

Total Shares Bought

Total Shares Sold

6,519

ACAD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 2, 2025	Sell	1,600	$25.98	$41.6K	0
Mar 5, 2025	Sell	4,919	$18.23	$89.7K	0

Related Insiders

James Kihara

PRINCIPAL ACCOUNTING OFFICER

ACADSell · Apr 7, 2026

Mark C. Schneyer

officer: EVP, CHIEF FINANCIAL OFFICER

ACADSell · Apr 7, 2026

Adams Catherine Owen

director, officer: Chief Executive Officer

ACADSell · Mar 26, 2026

Jennifer J Rhodes

officer: EVP, CHIEF LEGAL OFFICER, SEC

ACADSell · Mar 26, 2026

Elizabeth H.Z. Thompson

officer: EVP, Head of Research & Dev

ACADSell · Mar 26, 2026

James M Daly

Director

ACADSell · Nov 10, 2025

Laura Brege

Director

ACADSell · Jun 4, 2025

Explore More Insider Trading Data

ACAD Insider Trading Activity

View all insider trades at ACADIA Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity